Abstract
Plasma kinins are a family of peptides which play an important role in a variety of pathophysiological conditions. As a consequence of the progress in the area of kinin receptors, specific kinin receptor antagonists will be available in near future in order to provide more selective therapeutic modalities for the treatment of diseases such as asthma, cardiovascular diseases, inflammation, pain, etc. Although the initial observation leading to dicovery of kinins has been performed in 1909, important progress on the development of specific kinin receptor antagonists has been made in last two decades. This review emphesizes the physiological functions of kinins along with their receptor subtypes and post-receptor events in the cellular signaling. In this article, the latest developments in the kinin receptor antagonists including nonpeptide ones have been reviewed
Current Pharmaceutical Design
Title: Kinin Receptors and Their Antagonists as Novel Therapeutic Agents
Volume: 7 Issue: 2
Author(s): Yusuf Ozturk
Affiliation:
Abstract: Plasma kinins are a family of peptides which play an important role in a variety of pathophysiological conditions. As a consequence of the progress in the area of kinin receptors, specific kinin receptor antagonists will be available in near future in order to provide more selective therapeutic modalities for the treatment of diseases such as asthma, cardiovascular diseases, inflammation, pain, etc. Although the initial observation leading to dicovery of kinins has been performed in 1909, important progress on the development of specific kinin receptor antagonists has been made in last two decades. This review emphesizes the physiological functions of kinins along with their receptor subtypes and post-receptor events in the cellular signaling. In this article, the latest developments in the kinin receptor antagonists including nonpeptide ones have been reviewed
Export Options
About this article
Cite this article as:
Yusuf Ozturk , Kinin Receptors and Their Antagonists as Novel Therapeutic Agents, Current Pharmaceutical Design 2001; 7 (2) . https://dx.doi.org/10.2174/1381612013398338
DOI https://dx.doi.org/10.2174/1381612013398338 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Curcumin Activates Erythrocyte Membrane Acetylcholinesterase
Letters in Drug Design & Discovery The Proteasome in Health and Disease
Current Pharmaceutical Design Strategies to Control Human Lymphatic Filarial Infection: Tweaking Host’s Immune System
Current Topics in Medicinal Chemistry Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea: A Two-Faced Janus
Current Respiratory Medicine Reviews Vitamin D and Atopic Dermatitis
Mini-Reviews in Medicinal Chemistry Review in Pharmacokinetic Models on Corticosteroids
Mini-Reviews in Medicinal Chemistry Cytokines in Human Breast Milk: Immunological Significance for Newborns
Current Nutrition & Food Science New Uses of Melatonin as a Drug; A Review
Current Medicinal Chemistry Quantitative Structure Activity Relationship Studies of Piperazinyl Phenylalanine Derivatives as VLA-4/VCAM-1 Inhibitors
Medicinal Chemistry The Role of Inspiratory Pressures in Determining the Flow Rates Though Dry Powder Inhalers; A Review
Current Pharmaceutical Design The Molecular Mechanisms of Glucocorticoids-Mediated Neutrophil Survival
Current Drug Targets Cytochrome P450 and the Biological Clock in Mammals
Current Drug Metabolism Development and Production of Commercial Therapeutic Monoclonal Antibodies in Mammalian Cell Expression Systems: An Overview of the Current Upstream Technologies
Current Pharmaceutical Biotechnology The Mechanism of Adjuvanticity of Aluminium-Containing Formulas
Current Pharmaceutical Design Selection of Potential Pharmacological Targets in ALS Based on Whole- Genome Expression Profiling
Current Medicinal Chemistry Meet Our Editorial Board Member
Current Medicinal Chemistry Targeting Interleukin-21 in Immune-Mediated Pathologies
Current Drug Targets Novel Approaches for Allergy
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Potential Applications of FDG-PET/CT in COPD: A Review of the Literature
Current Molecular Imaging (Discontinued) Metabolic Changes in Autoimmune Diseases
Current Drug Discovery Technologies